Neurology devices are specialized surgical devices used for the treatment of disease or conditions of the central nervous system (CNS) and spine. External ventricular drainage (EVD) and microtransducer devices are covered under this market. GlobalData uses proprietary data and analytics to provide a comprehensive report on the icp monitoring devices devices market, including market shares of different players within Belgium. Buy the latest report here.
Smarter leaders trust GlobalData
In 2021, GlobalData’s Market Model methodology determined that the leading player in the icp monitoring devices market in Belgium was Integra LifeSciences followed by Natus Medical, Spiegelberg, Medtronic, Raumedic and Sophysa.
The External Ventricular Drainage (EVD) is a kit along with a small tube surgically inserted that allows the temporary drainage of CSF from the ventricles of the brain, which helps to relieve intracranial pressure. Microtransducer Devices are devices which are used primarily for measurement of ICP.
Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the icp monitoring devices devices market within Belgium was expected to be over $0.3m in 2021.
For the latest complete market share analysis of icp monitoring devices device market in Belgium, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
